微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 31.18% | -4.32% | -0.08% | 108/142 | 52.32% | 佰仁医疗 | 88.31% | 行业排名> |
| 2026-06-30 | 31.2% | -4.46% | -0.95% | 109/142 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 31.5% | -1.62% | -4.72% | 107/142 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 33.06% | 1.64% | 1.47% | 104/142 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 32.59% | 4.12% | -0.23% | 107/142 | 52.29% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 32.66% | 8.18% | 2% | 108/142 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 32.02% | 3.55% | -1.56% | 106/142 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 32.53% | 0.11% | 3.94% | 110/142 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 31.3% | -4.06% | 3.66% | 108/142 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 30.19% | -9.31% | -2.37% | 112/142 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 30.92% | -10.11% | -4.83% | 106/142 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 32.49% | -3.53% | -0.39% | 109/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 32.62% | -3.82% | -2.01% | 104/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 33.29% | -4.09% | -3.24% | 108/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 34.4% | -0.71% | 2.14% | 101/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 33.68% | -12.24% | -0.69% | 109/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 33.92% | -11.69% | -2.29% | 102/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 34.71% | -7.23% | 0.18% | 106/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 34.65% | -5.1% | -9.73% | 94/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 38.38% | 2.68% | -0.06% | 107/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 38.4% | 0.4% | 2.65% | 93/142 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 37.41% | -0.31% | 2.47% | 100/142 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 36.51% | 3.18% | -2.32% | 86/142 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 37.38% | -1.33% | -2.28% | 110/142 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 38.25% | 4.21% | 1.93% | 77/142 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 37.53% | 2.99% | 6.06% | 94/142 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 35.38% | 0.96% | -6.6% | 65/142 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 37.88% | 8.68% | 3.2% | 96/142 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 36.71% | 7.5% | 0.74% | 52/142 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 36.44% | 10.02% | 3.97% | 61/142 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 35.05% | 8.72% | 0.54% | 44/142 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 34.86% | 4.23% | 2.09% | 92/142 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 34.15% | 2.92% | 3.1% | 40/142 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 33.12% | -0.02% | 2.74% | 49/142 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 32.24% | -3.92% | -3.61% | 42/142 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 33.44% | 1.13% | 0.81% | 87/142 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 33.18% | 0.86% | 0.15% | 38/142 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 33.13% | 0.73% | -1.27% | 48/142 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 33.55% | 2% | 1.46% | 37/142 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 33.07% | 7.23% | 0.53% | 68/142 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 32.89% | 2% | 0.02% | 35/142 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 32.89% | 9.63% | 6.64% | 43/142 | 52.6% | *ST明德 | 86.71% | 行业排名> |